GHP Q2 2019

Q2 2019 www.ghp-news.com ghp Research, Translation, Commercialisation FDA Approves First Chemoimmunotherapy Regimen For Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma At the Cutting Edge of Pharmaceutical Innovation AAPS Also in this issue... The Menopause Clinic London The North West Pain Centre Scott Arms Dental Practice The Sebastian Liew Centre SPLICE Agency MDDUS